INTRODUCTION
In patients with acromegaly, obstruction of the upper airway may develop due to enlargement of the tongue and thickening of the tissues of the larynx. Acromegaly is often associated with obstructive sleep apnea syndrome (OSAS). OSAS is due to craniofacial changes and acromegaly. Although the obstructive type of apnea was thought to be predominant, there are some reports suggesting that central apneic episodes have a high rate and are related to abnormalities of central respiratory control. The presence and importance of central sleep apnea in acromegaly are unsolved issues. Morphological changes so characteristic of acromegaly stand for an obstructive type of apnea.The hormonal milieu that determines the predominance of the type of apnea is not yet fully understood.
CASE PRESENTATION
A 51-year-old male patient presented with a complaint of breathlessness during his sleep. His medical history included surgery for a growth hormone (GH)-releasing pituitary adenoma in 2007. A recurrent adenoma was detected in followup magnetic resonance imaging performed in 2012; the size of the lesion had not changed in the follow-ups ( Figure  1 ). Due to concomitant diabetes mellitus and hypertension, medical treatment was provided, and somatostatin was used as the GH antagonist. The patient had the phenotype of acromegaly and experienced sleep problems. Therefore, polysomnography (PSG) was performed to evaluate the patient with respect to sleep apnea syndrome. The patient did not complain of snoring or daytime sleepiness. His body mass index was 34.2 kg/m 2 , and his Epworth sleepiness score was 2. The apnea-hypopnea index (AHI) was 58; 426 respiratory events occurred during sleep and 91 of these were obstructive, 5 were mixed, 287 were central sleep apnea, and 43 were hypopnea. The longest apnea duration was 34 s. With these findings, the patient was diagnosed as having "advanced grade central sleep apnea syndrome." The patient was evaluated to check whether he could undergo surgery, but surgery was not considered because of the localization of the lesion. An upper respiratory tract endoscopic examination did not reveal any pathology, and the patient was prescribed Continuous Positive Airway Pressure (CPAP) at a pressure of 9 cmH 2 O. Polysomnographic findings are presented in Table 1 .
Informed consent was obtained from the patient who participated in this study. 
DISCUSSION
Acromegaly is characterized by somatic findings due to soft tissue hypertrophy and systemic findings such as diabetes, heart failure, and hypertension. The somatic effect of increased GH and IGF-1 levels in the body is growth stimulation in skin, bone, cartilage, connective, and other epithelial tissues [1] . Hypertrophy of the respiratory mucosa and upper respiratory soft tissue and macroglossia lead to the development of OSAS, and its prevalence rate is reported to be 80-90% [2, 3] . Central obesity increases the risk of OSAS by 2-4 times in the general population, and body composition alterations can partially explain the persistence of this respiratory disturbance in cured acromegalic patients. A reduction in water and lean body mass and an increase in body fat were observed after achieving biochemical control of the disease [4] . Patients with GH deficiency can develop central obesity and impaired glucose metabolism, thus increasing the risk of sleep disorders. GH/IGF-1 contributes to the disruption of respiratory control (respiratory instability), and GH levels contribute to the development of central apnea [5] . Besides data showing that sleep breathing disorders (SBDs) completely resolve with the treatment of acromegaly, there are results showing that SBDs persist due to permanent structural changes [6] . CPAP treatment is effective for controlling sleep disorders in acromegaly, while there are discordant results about GH/ IGF-1 normalization and OSAS improvement. Chemla et al. [7] reported that acromegaly control (obtained with surgery or medical treatment) had no significant effect on polysomnographic indices. Extensive CPAP studies have shown several cardiovascular benefits; therefore, it is reasonable to suppose that treating OSAS can improve the long-term cardiovascular prognosis in acromegalic patients. Regarding comorbidities, diabeetes mellitus (DM) or Impaired Glucose Tolerange (IGT) was more prevalent in OSAS patients, probably because this sleep disorder decreases insulin secretion and increase insulin resistance, as already known [8] . Diabetes can have a negative impact on life expectancy in the general population; in the literature, it is described as an independent predictor of mortality in acromegaly. Therefore, this comorbidity should be considered and managed with specific treatments, including diet, physical activity, oral antidiabetic drugs, and insulin [9] .
Positive Airway Pressure (PAP) treatment for acromegaly patients with OSAS should not be overlooked [6] .
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